Sanchez Marina, Darimont Christian, Panahi Shirin, Drapeau Vicky, Marette André, Taylor Valerie H, Doré Jean, Tremblay Angelo
Faculty of Medicine, Department of Kinesiology, Laval University, Quebec, QC G1V 0A6, Canada.
Nestlé Research Center, Department of Metabolic Health, 1000 Lausanne, Switzerland.
Nutrients. 2017 Mar 15;9(3):284. doi: 10.3390/nu9030284.
This study evaluated the impact of probiotic supplementation (Lactobacillus rhamnosus CGMCC1.3724 (LPR)) on appetite sensations and eating behaviors in the context of a weight-reducing program. Obese men ( = 45) and women ( = 60) participated in a double-blind, randomized, placebo-controlled trial that included a 12-week weight loss period (Phase 1) based on moderate energy restriction, followed by 12 weeks of weight maintenance (Phase 2). During the two phases of the program, each subject consumed two capsules per day of either a placebo or a LPR formulation (10 mg of LPR equivalent to 1.6 108 CFU/capsule, 210 mg of oligofructose, and 90 mg of inulin). The LPR supplementation increased weight loss in women that was associated with a greater increase in the fasting desire to eat ( = 0.03). On the other hand, satiety efficiency (satiety quotient for desire to eat) at lunch increased ( = 0.02), whereas disinhibition ( = 0.05) and hunger ( = 0.02) scores decreased more in the LPR-treated women, when compared with the female control group. Additionally, the LPR female group displayed a more pronounced decrease in food craving ( = 0.05), and a decrease in the Beck Depression Inventory score ( = 0.05) that was significantly different from the change noted in the placebo group ( = 0.02), as well as a higher score in the Body Esteem Scale questionnaire ( = 0.06). In men, significant benefits of LPR on fasting fullness and cognitive restraint were also observed. Taken together, these observations lend support to the hypothesis that the gut-brain axis may impact appetite control and related behaviors in obesity management.
本研究评估了在减肥计划中补充益生菌(鼠李糖乳杆菌CGMCC1.3724,即LPR)对食欲感知和饮食行为的影响。45名肥胖男性和60名肥胖女性参与了一项双盲、随机、安慰剂对照试验,该试验包括一个基于适度能量限制的12周体重减轻期(第一阶段),随后是12周的体重维持期(第二阶段)。在该计划的两个阶段中,每位受试者每天服用两粒胶囊,胶囊内容物要么是安慰剂,要么是LPR制剂(10毫克LPR,相当于1.6×10⁸CFU/胶囊,210毫克低聚果糖,以及90毫克菊粉)。补充LPR使女性体重减轻增加,这与空腹时进食欲望的更大增加相关(P = 0.03)。另一方面,与女性对照组相比,LPR治疗组女性午餐时的饱腹感效率(进食欲望的饱腹感商数)增加(P = 0.02),而抑制解除(P = 0.05)和饥饿感(P = 0.02)得分下降更多。此外,LPR女性组的食物渴望下降更为明显(P = 0.05),贝克抑郁量表得分下降(P = 0.05),与安慰剂组的变化(P = 0.02)有显著差异,并且在身体自尊量表问卷中的得分更高(P = 0.06)。在男性中,也观察到LPR对空腹饱腹感和认知抑制有显著益处。综上所述,这些观察结果支持了以下假设:肠-脑轴可能会影响肥胖管理中的食欲控制及相关行为。